High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand
about
Designer drugs 2015: assessment and management.High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug.Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.PET tracers for serotonin receptors and their applicationsEvolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.Chemistry and Structure-Activity Relationships of Psychedelics.Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers
P2860
Q30300017-8EA4F7F2-3C45-42ED-950F-B8ED7BD0527CQ33829385-166EDB48-183A-4CE8-A02D-0C5CF66EF0F3Q34025072-9F4F8ED9-1D5A-4FF7-80F0-8D6FD172ECD6Q34331924-BE279417-CD79-43B9-9922-922CF938330DQ34348317-39F97238-8041-4625-8A27-234E968F162FQ34369264-7B21DE3B-BC71-41AA-B195-302466B04F56Q34419823-B957DBED-E223-4D3D-A0A9-E545361AEC17Q34438870-6D6F9E72-7AE8-4BB0-87F8-01B0DAD56CE7Q34546304-71290A3B-FE0D-4F9D-9EF5-8F69FF4019A0Q35090637-4CAC08E4-5F3B-40D2-91F2-5BCA015E9663Q35749149-B1839632-BACA-453D-A64B-935E01252C4FQ36751879-B17B9A5B-42E3-4E65-83A0-39654567FE4CQ37630040-6408EAA7-F160-475D-A6BA-A13A9E74A1CFQ37633498-EC187AB5-55D0-4647-B89B-FDCE239D23C6Q37672302-76046979-1535-4A47-BE0B-E5299AE1BCA3Q37728569-876780B1-21EC-4D2A-A06C-E238C0F920DCQ38208426-61D82BF8-745C-4680-88E3-4E625B25B32EQ38841130-C47621BC-F40F-4B32-BB24-88AEFDAF2354Q39093171-790880AF-727B-48FB-A5FB-A08C67D4734FQ39569585-B44CE228-F4B1-498C-8818-A619D1D42B60Q48069477-F81A602C-76B6-42EA-8BDE-865D96D710CAQ50674127-47FF38C7-BABB-48D0-B346-A39AFDEEF7F9Q59218493-14DCA855-DDD4-4C96-96A7-72A8C553691F
P2860
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
High specific activity tritium ...... -selective agonist radioligand
@ast
High specific activity tritium ...... -selective agonist radioligand
@en
High specific activity tritium ...... -selective agonist radioligand
@nl
type
label
High specific activity tritium ...... -selective agonist radioligand
@ast
High specific activity tritium ...... -selective agonist radioligand
@en
High specific activity tritium ...... -selective agonist radioligand
@nl
prefLabel
High specific activity tritium ...... -selective agonist radioligand
@ast
High specific activity tritium ...... -selective agonist radioligand
@en
High specific activity tritium ...... -selective agonist radioligand
@nl
P2093
P2860
P1476
High specific activity tritium ...... -selective agonist radioligand
@en
P2093
Anita H Lewin
Benjamin R Chemel
David E Nichols
Desong Zhong
Kenneth S Rehder
Stewart P Frescas
P2860
P304
P356
10.1016/J.BMC.2008.04.050
P407
P577
2008-06-01T00:00:00Z